Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk | Zendy

Sanne W. ten Broeke | Zendy; Richard M. Brohet | Zendy; Carli M.J. Tops | Zendy; Heleen M. van der Klift | Zendy; Mary E. Velthuizen | Zendy; Inge Bernstein | Zendy; Gabriel Capellá | Zendy; E. Gómez | Zendy; Nicoline Hoogerbrugge | Zendy; Tom G.W. Letteboer | Zendy; Fred H. Menko | Zendy; Annika Lindblom | Zendy; Arjen R. Mensenkamp | Zendy; Pål Møller | Zendy; Theo A. van Os | Zendy; Nils Rahner | Zendy; Bert J. W. Redeker | Zendy; Rolf H. Sijmons | Zendy; Liesbeth Spruijt | Zendy; Ma Suerink | Zendy; Yvonne J. Vos | Zendy; Anja Wagner | Zendy; Frederik J. Hes | Zendy; Hans F. A. Vasen | Zendy; Maartje Nielsen | Zendy; Juul Wijnen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk

Author(s) -

Sanne W. ten Broeke,

Richard M. Brohet,

Carli M.J. Tops,

Heleen M. van der Klift,

Mary E. Velthuizen,

Inge Bernstein,

Gabriel Capellá,

E. Gómez,

Nicoline Hoogerbrugge,

Tom G.W. Letteboer,

Fred H. Menko,

Annika Lindblom,

Arjen R. Mensenkamp,

Pål Møller,

Theo A. van Os,

Nils Rahner,

Bert J. W. Redeker,

Rolf H. Sijmons,

Liesbeth Spruijt,

Ma Suerink,

Yvonne J. Vos,

Anja Wagner,

Frederik J. Hes,

Hans F. A. Vasen,

Maartje Nielsen,

Juul Wijnen

Publication year - 2014

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2014.57.8088

Subject(s) - lynch syndrome , pms2 , medicine , germline mutation , endometrial cancer , colorectal cancer , oncology , cancer , family history , proband , mlh1 , mutation , gynecology , genetics , dna mismatch repair , biology , gene

The clinical consequences of PMS2 germline mutations are poorly understood compared with other Lynch-associated mismatch repair gene (MMR) mutations. The aim of this European cohort study was to define the cancer risk faced by PMS2 mutation carriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research